Blue Mountain Announces Launch of Blue Mountain University: A Premier e-Learning Experience for RAM Software Users
16 oct. 2024 09h00 HE
|
Blue Mountain
Blue Mountain announces the launch of Blue Mountain University, an eLearning platform for RAM software users to enhance skills, efficiency, and compliance.
Curia Commits to SBTi Net-Zero Standard
08 oct. 2024 09h00 HE
|
Curia Global, Inc.
Curia today announced its commitment to set near- and long-term greenhouse gas reductions in line with the Science Based Targets initiative (SBTi).
Blue Mountain and Apprentice.io Announce Groundbreaking Integration of EAM and MES Technologies, Transforming Asset Performance Management for Life Sciences Manufacturing
03 oct. 2024 09h00 HE
|
Blue Mountain; Apprentice.io
Blue Mountain & Apprentice.io announce groundbreaking integration of EAM & MES technologies for life sciences manufacturers.
Monthly information on share capital and company voting rights
02 oct. 2024 16h30 HE
|
Cellectis Inc.
PARIS, Oct. 02, 2024 (GLOBE NEWSWIRE) -- Listing market: Euronext Growth ISIN code: FR0010425595 DateTotal number of sharesin the capitalTotal number of voting...
Big4Bio Names David J. Whelan Its New Chief Business Officer
02 oct. 2024 07h30 HE
|
BigBio Communications
SAN FRANCISCO, Oct. 02, 2024 (GLOBE NEWSWIRE) -- BigBio Communications is excited to announce that it is expanding the Big4Bio leadership team with the appointment of David J. Whelan as Chief...
NurExone Biologic Announces Private Placement of up to $2M and Closes First Tranche for $1.61M
26 sept. 2024 16h03 HE
|
NurExone Biologic Inc
NurExone Biologic Announces Private Placement of up to $2M and Closes First Tranche for $1.61M
Pivotal Hits Industry Milestone, Surpassing 1,000 Crewed eVTOL Flights
25 sept. 2024 08h00 HE
|
Pivotal
Pivotal, the leader in light electric Vertical Takeoff and Landing (eVTOL) aircraft, has achieved 1,117 crewed flights in its BlackFly, a category first
Lipella Pharmaceuticals Reports Encouraging Early Tolerability Results in Phase 2a Trial of LP-310 for Oral Lichen Planus
24 sept. 2024 08h00 HE
|
Lipella Pharmaceuticals Inc.
Lipella Pharmaceuticals Reports Encouraging Early Tolerability Results in Phase 2a Trial of LP-310 for Oral Lichen Planus
Helsinn Group appoints Riccardo Carbucicchio to the Board of Directors
19 sept. 2024 08h00 HE
|
Helsinn Healthcare S.A.
Helsinn Group appoints Riccardo Carbucicchio to the Board of Directors Lugano, Switzerland – September 19, 2024 – Helsinn Group (“Helsinn”), a global pharmaceutical company with a track record of...
CSL schließt sich Accumulus Synergy an, um den Wandel der Branche voranzutreiben
17 sept. 2024 09h05 HE
|
Accumulus Synergy
BURLINGAME, Kalifornien, Sept. 17, 2024 (GLOBE NEWSWIRE) -- Accumulus Synergy, Inc. („Accumulus“) und seine Gründungssponsoren sind stolz darauf, CSL als erstes Mitgliedsunternehmen begrüßen zu...